Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Sewell › NPI 1396802658
Physician

Ra Pain Services PA

Ra Pain Services PA was paid $6.26M by Medicaid between Jan 2018 and Feb 2024, across 28 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 64% of everything it billed.

33Billing provider infoRA PAIN SERVICES PA
SEWELL, NJ 08080
33aNPI1396802658assigned 01/03/2007
28Total paid$6.26M
24GClaims174,266
24DCodes billed28
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in New Jersey

Rank by total paid#2 of 35
Median peer was paid$38K
This provider vs. median165×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201824,804$1.17M
201924,351$1.08M
202025,357$966K
202127,516$843K
202232,416$1000K
202334,168$1.01M
2024incomplete5,654$186K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 64% 118,788 113,584 $4.01M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 32,734 31,658 $1.65M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 7.1% 3,958 3,884 $444K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 316 316 $26K
99442 <1% 2,365 2,330 $23K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,430 4,010 $22K
95886 <1% 392 353 $21K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,610 5,048 $15K
76942 <1% 241 207 $8K
62323 <1% 33 32 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 271 266 $7K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 664 575 $3K
16 more codes
20611 <1% 108 $3K
99443 <1% 133 $2K
20610 <1% 31 $2K
64493 <1% 24 $2K
J3490 Unclassified drugs <1% 1,962 $1K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 53 $815.75
64494 <1% 12 $550.08
77003 <1% 847 $547.57
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 651 $512.79
96156 <1% 137 $463.26
90834 Psychotherapy session, about 45 minutes <1% 108 $455.93
96158 <1% 159 $384.18
20552 <1% 15 $313.80
99441 <1% 12 $105.56
96159 <1% 84 $97.35
A4550 Surgical trays 0% 128 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHALEEM, BURHAN (PHYSICIAN PARTNER)
Same official

Other billing entities under HALEEM, BURHAN

Full network →
ProviderLocationPaid
Minimally Invasive Surgery Center, P.A.Linwood, NJ$11K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.